• Explore /
  • Poster
  • / Evaluation of miR 31 3p as a biomarker of prognosis and panitumumab benefit in <i>RAS</i>-wt advanced colorectal cancer (aCRC): Analysis of patients (pts) from the PICCOLO trial.

Evaluation of miR 31 3p as a biomarker of prognosis and panitumumab benefit in RAS-wt advanced colorectal cancer (aCRC): Analysis of patients (pts) from the PICCOLO trial.

Abstract Poster

Authors

null

Pierre Laurent-Puig

UMR-S1147, INSERM, Paris Descartes University, Paris, France

Pierre Laurent-Puig , Sophie Paget-Bailly , Dewi Vernerey , Celine Vazart , Virginie Decaulne , Karine Fontaine , Francis Rousseau , Faye Elliott , Philip Quirke , Susan Richman , Jenny Seligman , Matthew T. Seymour , Franck Bonnetain , Francois Liebaert , Raphaële Thiébaut

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer

Citation

J Clin Oncol 33, 2015 (suppl; abstr 3547)

DOI

10.1200/jco.2015.33.15_suppl.3547

Abstract #

3547

Poster Bd #

39

Abstract Disclosures

Similar Posters

First Author: Jenny F. Seligmann

First Author: Jenny F. Seligmann

First Author: Olatunji B. Alese

First Author: Sheng Li